Financial Metrics Check: Standard BioTools Inc (LAB)’s Ratios for Trailing Twelve Months

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

As of close of business last night, Standard BioTools Inc’s stock clocked out at $1.33, up 2.31% from its previous closing price of $1.30. In other words, the price has increased by $2.31 from its previous closing price. On the day, 1.35 million shares were traded.

Ratios:

To gain a deeper understanding of LAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.76. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on April 16, 2024, initiated with a Buy rating and assigned the stock a target price of $3.50.

On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $3.25.

On July 12, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $4.KeyBanc Capital Markets initiated its Overweight rating on July 12, 2023, with a $4 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when Black Jeffrey G. bought 57,971 shares for $2.12 per share.

Taich Adam bought 45,851 shares of LAB for $91,725 on Sep 09 ’24. On Aug 27 ’24, another insider, Casdin Partners Master Fund, L, who serves as the Director of the company, bought 250,000 shares for $2.19 each. As a result, the insider paid 546,750 and bolstered with 54,025,821 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.18 while its Price-to-Book (P/B) ratio in mrq is 1.01.

Stock Price History:

Over the past 52 weeks, LAB has reached a high of $3.04, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is -21.59%, while the 200-Day Moving Average is calculated to be -31.10%.

Shares Statistics:

A total of 372.26M shares are outstanding, with a floating share count of 360.47M. Insiders hold about 3.17% of the company’s shares, while institutions hold 72.48% stake in the company.

Most Popular